Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stina Wichert

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Scientific Reports|December 20, 2023
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulinMikael Lisak, Malin Nicklasson, Robert Palmason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple MyelomaMarkus Hansson, Peter Gimsing, Ashraf Badros, et al.
Frontiers in Immunology|December 27, 2023
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Scientific Reports|December 20, 2023
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulinMikael Lisak, Malin Nicklasson, Robert Palmason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple MyelomaMarkus Hansson, Peter Gimsing, Ashraf Badros, et al.
Frontiers in Immunology|December 27, 2023
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Pageof 2